For every life that is saved by breast cancer screening up to TEN women suffer 'unnecessary treatment' including breast removals

'We've exaggerated the benefits of screening and we've
ignored the harm,' says expert

|

UPDATED:

10:55 GMT, 3 April 2012

Thousands of women are undergoing unnecessary treatment for breast cancer including chemotherapy and even breast removal following screening, researchers have found.

Academics from Harvard School of Public Health studied the results from 40,000 women who were screened in Norway.

They found for every 2,500 women offered screening, one death from
breast cancer would be prevented – but six to 10 women would be treated for a benign cancer that would never cause symptoms.

Enlarge

 Radiology technician performs mammography test

Research: A study estimated that for every 2,500 women offered screening, one death from breast cancer will be prevented but six to 10 women will be overdiagnosed and treated

This 'overdiagnosis' results in thousands of women receiving damaging treatment including surgery, powerful drugs like tamoxifen and chemotherapy. If the cancer appears aggressive the decision may be made to remove the whole breast – a procedure known as a mastectomy.

The Harvard study is the latest in a recent slew of research to question the long-held belief that the benefits of national
screening programmes far outweigh the harm they can cause.

In the UK, the NHS screens around 1.6million women for breast cancer every year. Women aged from 47 to 73 are invited to screening every three years as the risk of developing the condition increases with age.

Breast cancer deaths have fallen by more than 10 per cent in Britain over the past five years, which Stephen Duffy from Cancer Research UK said was partly due to screening.

However, a recent study from the International Prevention Research Institute in Lyon, France, suggested better treatments are more likely to be causing the recent drop in death rates.

There is currently an independent review underway into whether the UK programme causes more benefit than harm.

A Department of Health spokesman said: 'Our screening programme is regularly scrutinised.

'We
know that there are some scientists who differ in their views towards
screening, so as requested by ministers, the National Cancer Director
Professor Sir Mike Richards has commissioned an independent review of
the evidence in partnership with Harpal Kumar, chief executive of Cancer
Research UK.'

In the latest study the Harvard researchers estimate that up to a quarter of breast cancers
found by mammograms won't cause any problems during a woman's
lifetime.

Once cancer is found, however, doctors must treat it as they do not yet have an effective technique of working out which ones
will be dangerous.

'When
you look for cancer early and you look really hard, you find forms that
are ultimately never going to bother the patient,' said Dr H. Gilbert
Welch of the Dartmouth Institute for Health Policy and Clinical
Practice, who was not part of the research.

BREAST CANCER RISK

In 2008 the estimated risk at birth up to and including…

AGE
RISK
29
One in 2000
39
One in 215
49
One in 50
59
One in 22
69
One in 13
Lifetime
One in 8

'It's a side effect of early
diagnosis.'

The study from Harvard School of Public Health is the latest to
explore overdiagnosis from routine mammograms – finding tumors that grow
so slowly or not at all and that would not have caused symptoms or
death. Previous estimates of the problem have varied.

The
researchers took advantage of the staggered decade-long introduction of
a screening program in Norway, starting in 1996. That allowed them to
compare the number of breast cancers in counties where screening was
offered with those in areas that didn't yet have the program. Their
analysis also included a decade before mammograms were offered.

Study leader Dr.
Mette Kalager and other experts said women need to be better informed
about the possibility that mammograms can pick up cancers that will
never be life-threatening when they consider getting screened.

'Once you've decided to undergo
mammography screening, you also have to deal with the consequences that
you might be overdiagnosed,' said Kalager, a breast surgeon at Norway's
Telemark Hospital and a visiting scientist at Harvard School of Public
Health.

'/04/03/article-2124322-0D0AA087000005DC-83_468x313.jpg” width=”468″ height=”313″ alt=”Doctor assisting a female patient for mammogram.” class=”blkBorder” />

New: The study is the latest to explore overdiagnosis from routine mammograms

Kalager
and her colleagues looked only at invasive breast cancer. The study did
not include DCIS, or ductal carcinoma in situ – an earlier stage cancer
confined to a milk duct.

Under the Norway program, screening was offered every two years to women ages 50 to 69.

Researchers
analysed nearly 40,000 breast cancer cases, including 7,793 that were
detected after routine screening began. They estimated that between
1,169 and 1,948 of those women were overdiagnosed and got treatment they
didn't need.

Their findings appear in Tuesday's Annals of Internal Medicine.

Commenting on the study Dr Welch said: 'The
truth is that we've exaggerated the benefits of screening and we've
ignored the harms.

'I think we're headed to a place where we
realize we need to give women a more balanced message: Mammography helps
some people but it leads others to be treated unnecessarily.'

An
editorial published with the study said overdiagnosis probably occurs
more often in the United States because American women often start
annual screening at an earlier age and radiologists in the U.S. are more
likely to report suspicious findings than those in Europe.

Radiologists
could help by raising the threshold for noting abnormalities, wrote Dr
Joann Elmore of the University of Washington School of Medicine and Dr.
Suzanne Fletcher of Harvard Medical School.

A 'watch-and-wait' approach has been suggested instead of an immediate
biopsy, but the editorial writers acknowledge that could be a 'tough
sell' for some women and radiologists alike.

They said most women aren't aware of the possibility of overdiagnosis.

'We have an ethical responsibility to alert women to this phenomenon,' they wrote.